Aflibercept Dose in Polypoidal Choroidal Vasculopathy
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Aflibercept Dose in Polypoidal Choroidal Vasculopathy
-
Narrated by:
-
Written by:
Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
- Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
adbl_web_anon_alc_button_suppression_c
No reviews yet